| Entry |
|
|---|
| Name |
Fluindione (INN);
Previsccan (TN) |
|---|
| Formula |
C15H9FO2
|
|---|
| Exact mass |
240.0587
|
|---|
| Mol weight |
240.2292
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01708 Coumarin anticoagulant
DG01761 Phenindion type coumarin derivative
|
|---|
| Remark |
|
|---|
| Efficacy |
Anticoagulant, Vitamin K antagonist |
|---|
| Comment |
Phenindione (indandione) derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AA Vitamin K antagonists
B01AA12 Fluindione
D07969 Fluindione (INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01708 Coumarin anticoagulant
DG01761 Phenindion type coumarin derivative
D07969 Fluindione
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Vitamin-K-epoxide reductase
VKORC1
D07969 Fluindione (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8x C 12.9500 -19.5300
2 C8x C 12.9500 -20.9300
3 C8x C 14.1624 -21.6300
4 C8y C 15.3749 -20.9300
5 C8y C 15.3749 -19.5300
6 C8x C 14.1624 -18.8300
7 C5x C 16.7064 -21.3626
8 C1y C 17.5293 -20.2300
9 C5x C 16.7064 -19.0974
10 C8y C 18.9000 -20.2300
11 C8x C 19.6000 -21.4424
12 C8x C 21.0000 -21.4424
13 C8y C 21.7000 -20.2300
14 C8x C 21.0000 -19.0176
15 C8x C 19.6000 -19.0176
16 O5x O 17.1375 -22.6894
17 O5x O 17.1375 -17.7706
18 X F 23.1000 -20.2300
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 5 9 1
11 8 10 1
12 10 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 14 15 2
17 10 15 1
18 7 16 2
19 9 17 2
20 13 18 1
|
|---|
